Protherics PLC

Protherics is a leading biopharmaceutical company focused on developing, manufacturing and marketing critical care and cancer products. We have developed two FDA approved products in-house, CroFabÔ and DigiFabÔ. Our plan is to use revenues from our marketed products and licensing income to help fund the development of a robust and high value pipeline of products. We seek to use industry collaborations and M&A to achieve our goals in an industry where critical mass is needed to achieve long-term growth. In December 2006, we announced a ,38.2 million fundraising and the signing of three key agreements to expand our development ( www.protherics.com )